Evidence map›Paper›PMID 21914803›Full record

ArticleThe Journal of biological chemistry2011

Structural variation in bacterial glyoxalase I enzymes: investigation of the metalloenzyme glyoxalase I from Clostridium acetobutylicum.

Uthaiwan Suttisansanee, Kelvin Lau, Satyanarayana Lagishetty, Krishnamurthy N Rao, Subramanyam Swaminathan, J Michael Sauder, Stephen K Burley, John F Honek

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Identification of glyoxalase A in group BInfection and immunity · 2025
    Article
  2. Identification of Glyoxalase A in Group BbioRxiv : the preprint server for biology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. GLO1 Contributes to the Drug Resistance ofInfection and drug resistance · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Genome-Wide Identification of Glyoxalase Genes inFrontiers in plant science · 2017
    Article
  13. Article
  14. Article
  15. Structure of the novel monomeric glyoxalase I from Zea mays.Acta crystallographica. Section D, Biological crystallography · 2015
    Article
  16. Review
  17. Metal preferences and metallation.The Journal of biological chemistry · 2014
    Review
  18. Nonredox nickel enzymes.Chemical reviews · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Uthaiwan SuttisansaneeDepartment of Chemistry, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.
Kelvin LauDepartment of Chemistry, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.
Satyanarayana LagishettyBiology Department, Brookhaven National Laboratory, Upton, New York 11973.
Krishnamurthy N RaoBiology Department, Brookhaven National Laboratory, Upton, New York 11973.
Subramanyam SwaminathanBiology Department, Brookhaven National Laboratory, Upton, New York 11973.
J Michael SauderEli Lilly and Co., San Diego, California 92121.
Stephen K BurleyEli Lilly and Co., San Diego, California 92121. Electronic address: sburley@sgxpharma.com.
John F HonekDepartment of Chemistry, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada. Electronic address: jhonek@uwaterloo.ca.
Brookhaven National Laboratory · USUniversity of Waterloo · CAEli Lilly (United States) · US

Funding

SUBPROJECT 5U54GM074945 · NIGMS · SGX PHARMACEUTICALS, INC. · PI BURLEY, STEPHEN KEVIN · 2005 to 2009
$46.2M
NIGMS NIH HHS GM074945NIGMS NIH HHS U54 GM074945
6 · The paper itself

Abstract

The glyoxalase system catalyzes the conversion of toxic, metabolically produced α-ketoaldehydes, such as methylglyoxal, into their corresponding nontoxic 2-hydroxycarboxylic acids, leading to detoxification of these cellular metabolites. Previous studies on the first enzyme in the glyoxalase system, glyoxalase I (GlxI), from yeast, protozoa, animals, humans, plants, and Gram-negative bacteria, have suggested two metal activation classes, Zn(2+) and non-Zn(2+) activation. Here, we report a biochemical and structural investigation of the GlxI from Clostridium acetobutylicum, which is the first GlxI enzyme from Gram-positive bacteria that has been fully characterized as to its three-dimensional structure and its detailed metal specificity. It is a Ni(2+)/Co(2+)-activated enzyme, in which the active site geometry forms an octahedral coordination with one metal atom, two water molecules, and four metal-binding ligands, although its inactive Zn(2+)-bound form possesses a trigonal bipyramidal geometry with only one water molecule liganded to the metal center. This enzyme also possesses a unique dimeric molecular structure. Unlike other small homodimeric GlxI where two active sites are located at the dimeric interface, the C. acetobutylicum dimeric GlxI enzyme also forms two active sites but each within single subunits. Interestingly, even though this enzyme possesses a different dimeric structure from previously studied GlxI, its metal activation characteristics are consistent with properties of other GlxI. These findings indicate that metal activation profiles in this class of enzyme hold true across diverse quaternary structure arrangements.

Indexed as

Clostridium acetobutylicumCrystallography, X-RayDimerizationEnzyme ActivationKineticsLactoylglutathione LyaseLigandsMetalsModels, ChemicalMolecular ConformationNickelProtein ConformationRacemases and EpimerasesZincLactoylglutathione LyaseLigandsMetalsmethylmalonyl-coenzyme A racemaseNickelRacemases and EpimerasesZinc

Identifiers

PMID21914803
PMCPMC3207458
OpenAlexW2116144919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.